Pediatric Community-Acquired Brain Abscesses: A Single-center Retrospective Study

Pediatr Infect Dis J. 2024 Jun 1;43(6):e214-e217. doi: 10.1097/INF.0000000000004308. Epub 2024 Mar 5.

Abstract

The European Society for Clinical Microbiology and Infectious Diseases recommends 3rd generation cephalosporins and metronidazole for empirical treatment of community-acquired brain abscesses. In 53 retrospectively analyzed pediatric patients with community-acquired brain abscesses at a German University Hospital Staphylococcus aureus was identified as a relevant pathogen (21%). Therefore, it may be reasonable to cover S. aureus when selecting empirical therapy.

MeSH terms

  • Adolescent
  • Anti-Bacterial Agents* / therapeutic use
  • Brain Abscess* / drug therapy
  • Brain Abscess* / microbiology
  • Child
  • Child, Preschool
  • Community-Acquired Infections* / drug therapy
  • Community-Acquired Infections* / microbiology
  • Female
  • Germany / epidemiology
  • Humans
  • Infant
  • Male
  • Metronidazole / therapeutic use
  • Retrospective Studies
  • Staphylococcal Infections* / drug therapy
  • Staphylococcal Infections* / microbiology
  • Staphylococcus aureus* / drug effects